1. Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
- Author
-
Liu, Bolin, Li, Lingxia, Wang, Mengxin, Wei, Lichun, Li, Jia, Zou, Wei, Lv, Yanhong, Zhang, Hongju, and Liu, Shujuan
- Subjects
- *
QUALITY of life , *CERVICAL cancer , *CANCER patients , *LONGITUDINAL method , *CLINICAL trials , *TRACHELECTOMY - Abstract
To evaluate the health-related quality of life (HRQOL) in locally advanced cervical cancer (LACC) patients treated with neoadjuvant concurrent chemoradiation (CCRT) or radiation (RT) alone followed by radical surgery (RS). In a single-center retrospective study from a prospective database, 275 FIGO Stage IB2-IIIB patients who underwent CCRT/RT + RS were included. HRQOL was prospectively assessed by EORTC QLQ-C30 and EORTC QLQ-CX24 prior to any treatment (baseline) and 6 months after surgery, respectively. A statistically significant and clinically relevant improvement in physical functioning (P < 0.001) and role functioning (P = 0.002, P = 0.031) was observed in patients receiving either CCRT+RS or RT + RS at follow-up. In addition, quality of life (QoL), physical functioning, and social functioning were better in the RT + RS group than the CCRT+RS group after treatment (P = 0.028, P = 0.010, P = 0.014). Symptom scores of fatigue decreased in both groups over time (P < 0.001, P = 0.004) while insomnia decreased only in the RT + RS group (P = 0.042). Worsened menopausal symptoms were documented in both groups at follow-up (P = 0.001, P = 0.047), while lymphedema was deteriorated only in patients receiving CCRT + RS (P < 0.001). Sexuality scores did not differ between groups or over time with the exception of sexual worry, which was deteriorated in patients receiving RT + RS (P = 0.042). QLQ-C30 functioning and tumor-related symptoms scores improved while lymphedema and menopausal symptoms worsened 6 months after neoadjuvant CCRT or RT alone followed by RS in LACC patients. Patients treated with RT + RS had a generally better HRQOL compared with those receiving CCRT+RS, though further validation with prospective randomized clinical trials is warranted. • Physical/role functioning improved 6 months after concurrent chemoradiation (CCRT)/radiation (RT) + radical surgery (RS). • Tumor-related symptoms of fatigue and insomnia decreased 6 months after treatment. • Treatment-related symptoms of lymphedema and menopausal symptoms increased after treatment. • Sexuality was not impaired significantly except for a worsened sexual worry in the RT + RS group. • Generally RT + RS seems superior to CCRT+RS with greater improvement in functioning and less toxicity. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF